85 related articles for article (PubMed ID: 20015301)
21. Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.
Rigacci L; Vitolo U; Nassi L; Merli F; Gallamini A; Pregno P; Alvarez I; Salvi F; Sancetta R; Castagnoli A; Versari A; Biggi A; Gregianin M; Pelosi E; Chisesi T; Bosi A; Levis A;
Ann Hematol; 2007 Dec; 86(12):897-903. PubMed ID: 17701410
[TBL] [Abstract][Full Text] [Related]
22. PET imaging in lymphoma.
Hutchings M
Expert Rev Hematol; 2009 Jun; 2(3):261-76. PubMed ID: 21082968
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin lymphoma in a bone marrow aspirate.
Parsons K; Leach M; Bain BJ
Am J Hematol; 2020 Mar; 95(3):328-329. PubMed ID: 31849091
[No Abstract] [Full Text] [Related]
24. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
26. Fluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?
Hofman MS
Leuk Lymphoma; 2012 Mar; 53(3):349-51. PubMed ID: 21973211
[No Abstract] [Full Text] [Related]
27. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
[TBL] [Abstract][Full Text] [Related]
28. The role of bone marrow biopsy in Hodgkin lymphoma staging: "to be, or not to be, that is the question"?
Hutchings M
Leuk Lymphoma; 2012 Apr; 53(4):523-4. PubMed ID: 22300347
[No Abstract] [Full Text] [Related]
29. [Polypositional quantitative scintigraphy of the bone marrow with Tc-99m sulfur colloid and In-113m in Hodgkin's disease].
Kanaev SV; Artiushkin AV; Volkov AA; Malinin AP; Shust VF
Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):11-6. PubMed ID: 7443644
[No Abstract] [Full Text] [Related]
30. Hodgkin lymphoma: protecting the victims of our success.
Cheson BD
J Clin Oncol; 2012 Dec; 30(36):4456-7. PubMed ID: 23150696
[No Abstract] [Full Text] [Related]
31. Hodgkin's lymphoma mimicking juvenile arthritis.
Del Torto M; Breda L; Di Marzio D; De Sanctis S; La Barba G; Chiarelli F
Clin Exp Rheumatol; 2010; 28(1):143. PubMed ID: 20346256
[No Abstract] [Full Text] [Related]
32. Positron emission tomography scanning in the assessment of patients with lymphoma.
Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
[TBL] [Abstract][Full Text] [Related]
33. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
Liu EB; Chen HS
Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.
Pakos EE; Fotopoulos AD; Ioannidis JP
J Nucl Med; 2005 Jun; 46(6):958-63. PubMed ID: 15937306
[TBL] [Abstract][Full Text] [Related]
35. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission.
Corapcioglu F; Oncel S; Berberoğlu K; Klç SC; Aydoğan A; Doğan S
J Pediatr Hematol Oncol; 2009 Jan; 31(1):74-5. PubMed ID: 19125095
[No Abstract] [Full Text] [Related]
36. Extranodal malignant lymphoma: detection with FDG PET versus CT.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Merkle E; Frickhofen N; Reske SN
Radiology; 1998 Feb; 206(2):475-81. PubMed ID: 9457202
[TBL] [Abstract][Full Text] [Related]
37. [Preliminary clinical application of new bone marrow imaging agent 99mTc-polyphase liposome in malignant lymphoma].
Yu BF
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):297-300. PubMed ID: 2272267
[TBL] [Abstract][Full Text] [Related]
38. Computed tomography of the abdomen in the malignant lymphomas.
Harell GS; Breiman RS; Glatstein EJ; Marshall WH; Castellino RA
Radiol Clin North Am; 1977 Dec; 15(3):391-400. PubMed ID: 601229
[No Abstract] [Full Text] [Related]
39. Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?
Brepoels L; Stroobants S
Hematol Oncol Clin North Am; 2007 Oct; 21(5):855-69. PubMed ID: 17908624
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
